Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Infusion for OHSS Prevention
NCT05198128Unknown
- Sponsor
- Al-Azhar University
- Start
- Mar 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
01
Overview
Randomised trial of calcium gluconate in ovarian hyperstimulation syndrome (OHSS) (2 arms), sponsored by Al-Azhar University. Primary endpoint: Incidence of Ovarian Hyperstimulation Syndrome at 1 year. Status: unknown.
02
Drugs
calcium gluconate
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT05198128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05198128.